Business Manager – Oncology

Purpose Lead the business management of a portfolio of precision oncology medicines for lung cancer from pre-launch stage onwards, ensuring robust pre-launch preparation, seamless launch readiness, integration into GSK systems, and strong in-market performance. Key Responsibilities Asset & Portfolio Strategy (Pre-Launch to Post-Launch) • From pre-launch, develop and maintain a clear business strategy and roadmap for lung cancer oncology assets, aligned with GSK’s oncology growth ambitions and patient impact goals. • Translate global and regional asset strategies into practical commercial plans, defining priorities, KPIs and performance targets across pre-launch, launch and post-launch phases. Launch Readiness & Commercial Operations • Starting in pre-launch, partner with Regulatory, Market Access, Medical, Supply Chain to ensure end-to-end launch readiness, including access timelines, submission plans and payer engagement strategies. • Support development and execution of access and reimbursement strategies for the new assets (e.g. evidence needs, value communication, payer materials) in line with global guidance and local requirements. Stakeholder & Customer Coordination • Act as a central coordination point between GSK and external partners, ensuring customer engagement remains clear and value-adding, and that inquiries on partner-related products are directed to the appropriate resources. Performance Management & Business Analytics • Track asset performance (e.g. launches, uptake, access, revenues, key customer metrics) versus plan and provide regular business reviews and insights to leadership. • Identify risks and opportunities across markets (regulatory, access, operational, competitive) and recommend pragmatic actions to optimise impact and manage risk. Risk & Issue Management • Escalate material risks to appropriate governance forums, support mitigation planning, and communicate impacts to stakeholders. Why You? • University degree in Business, Life Sciences, Pharmacy, or related discipline; postgraduate qualification (MBA or equivalent) an advantage. • Solid experience (typically 5+ years) in pharmaceutical business management, brand leadership, oncology and/or lung cancer experience strongly preferred. • Strong strategic and analytical skills; able to connect scientific, commercial, operational and integration considerations into clear business decisions for oncology lung cancer assets. • Excellent cross-functional leadership and programme management capabilities, comfortable operating in highly matrixed and evolving environments. • Clear, confident communication and influencing skills with senior stakeholders, field teams and external partners. • High resilience, pragmatism and problem-solving mindset, with strong focus on patient impact and business continuity. Skills Business Planning, Data to Insights, Digital Fluency, Launch Excellence, Scientific Literacy, Strategic Planning     Why GSK? Uniting science, technology and talent to get ahead of disease together.   GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale.   People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious fo